Profile
Hui S.
Chang worked as a Research Scientist at Cambridge Biotech Corp., Senior Manager at Nabi Biopharmaceuticals, and Manager at Vaccinex, Inc. He also served as the Chief Operating Officer at China-Biotics, Inc. from 2010 to 2012.
Chang holds an MBA and a doctorate from The Johns Hopkins University, as well as an undergraduate degree from the University of Maryland.
Former positions of Hui S. Chang
| Companies | Position | End |
|---|---|---|
China-Biotics, Inc.
 China-Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services China-Biotics, Inc. manufactures biotechnology products and supplements. The company was founded in 1999 and is headquartered in Shanghai, China. | Chief Operating Officer | 2012-01-05 |
| Cambridge Biotech Corp. | Corporate Officer/Principal | - |
| VACCINEX, INC. | Corporate Officer/Principal | - |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Training of Hui S. Chang
| The Johns Hopkins University | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VACCINEX, INC. | Health Technology |
| Private companies | 3 |
|---|---|
China-Biotics, Inc.
China-Biotics, Inc. Miscellaneous Commercial ServicesCommercial Services China-Biotics, Inc. manufactures biotechnology products and supplements. The company was founded in 1999 and is headquartered in Shanghai, China. | Commercial Services |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
| Cambridge Biotech Corp. | Health Technology |
- Stock Market
- Insiders
- Hui S. Chang
